TXNIP and Parkinson disease: While the precise implications of reduced TXNIP in advanced PD require further investigation, our results suggest that dysregulation of this key redox modulator may be a key feature of the complex neuropathology of PD in the SNpc, warranting further exploration of its role in neuronal vulnerability and disease progression.